Other equities research analysts have also recently issued research reports about the stock. Canaccord Genuity lifted their price target on shares of Canopy Growth from C$18.50 to C$26.00 and gave the stock a hold rating in a research note on Monday, February 12th. Cowen lifted their target price on shares of Canopy Growth from C$24.00 to C$44.00 in a research note on Monday, January 8th.
Shares of WEED traded down C$0.24 on Thursday, hitting C$30.01. 3,025,100 shares of the stock traded hands, compared to its average volume of 6,608,671. Canopy Growth has a one year low of C$6.58 and a one year high of C$44.00.
About Canopy Growth
Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc and changed its name to Canopy Growth Corporation in September 2015.
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.